1. Home
  2. ARQT vs MANU Comparison

ARQT vs MANU Comparison

Compare ARQT & MANU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$26.62

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo Manchester United Ltd.

MANU

Manchester United Ltd.

N/A

Current Price

$19.94

Market Cap

3.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
ARQT
MANU
Founded
2016
1878
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
ARQT
MANU
Price
$26.62
$19.94
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$34.00
N/A
AVG Volume (30 Days)
1.8M
307.2K
Earning Date
05-06-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
88.79
N/A
EPS
0.03
N/A
Revenue
$376,072,000.00
N/A
Revenue This Year
$34.85
N/A
Revenue Next Year
$29.39
$16.31
P/E Ratio
$824.50
N/A
Revenue Growth
91.34
N/A
52 Week Low
$16.68
$14.59
52 Week High
$31.77
$24.45

Technical Indicators

Market Signals
Indicator
ARQT
MANU
Relative Strength Index (RSI) 51.37 27.73
Support Level $24.91 $16.63
Resistance Level $25.21 $23.85
Average True Range (ATR) 1.03 0.53
MACD 0.22 -0.20
Stochastic Oscillator 59.88 6.61

Price Performance

Historical Comparison
ARQT
MANU

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About MANU Manchester United Ltd.

Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extends to many countries, supporting a diversified revenue model based on brand engagement and football-related content.

Share on Social Networks: